News Focus
News Focus
Followers 181
Posts 13314
Boards Moderated 0
Alias Born 08/06/2006

Re: Balltilian post# 6972

Thursday, 10/08/2015 12:42:21 PM

Thursday, October 08, 2015 12:42:21 PM

Post# of 37330
Others here see fair value at .33 per share minumum, despite the dilution that took place. A/S @ 200mn is almost maxed out from the latest 191mn shares O/S. Some warrants still left but Roth Capital Partners has been hired to restructure. My guess is they want the share price back up to $1 to meet NASDAQ requirements.

A couple of FDA approvals are expected by year end and they have a good pipeline. Stock way oversold...see RSI and other technicals. Generating more and more revenue and waiting on 3Q15 results.

Think this one make a major rebound by year end.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today